ライフサイエンスコーパス: sensorineural

1 al ear and hearing impairment (conductive or sensorineural) affect the majority of patients.

2 Typically, virus-induced hearing loss is sensorineural, although conductive and mixed hearing los

3 While most hearing loss in older adults is sensorineural and due to presbycusis, cerumen impaction

4 nly external and middle ear defects but also sensorineural and vestibular phenotypes observed in thes

5 r knowledge, this is the first non-syndromic sensorineural autosomal deafness susceptibility gene to

6 ate the terminal differentiation of distinct sensorineural cells in which they exhibit selective spat

7 critical period of synaptogenesis for these sensorineural cells.

8 ed1-Notch2 signaling is known to pattern the sensorineural components of the inner ear, its role in m

9 renal disease that is often associated with sensorineural deafness (Alport syndrome).

10 In 1960, progressive sensorineural deafness (McKusick 304,700, DFN-1) was sho

11 ed a unique, inbred Bedouin kindred in which sensorineural deafness (SND) cosegregates with an infant

12 with a 21-kb deletion in chromosome Xq22 and sensorineural deafness along with dystonia, we character

13 ion of symptoms, including epilepsy, ataxia, sensorineural deafness and a renal tubulopathy designate

14 Sensorineural deafness and balance dysfunction are commo

15 ogical disorder characterized by early-onset sensorineural deafness and brain anomalies.

16 aemia, mild thrombocytopenia and leucopenia, sensorineural deafness and diabetes mellitus.

17 Patients presented with early-onset sensorineural deafness and distal renal tubular acidosis

18 n is responsible for the familiar conditions sensorineural deafness and hypertrophic cardiomyopathy.

19 We report siblings with congenital sensorineural deafness and lactic acidemia in associatio

20 of mitochondrial RC dysfunction, congenital sensorineural deafness and progressive hepatic and renal

21 the inner ear, cause the autosomal dominant sensorineural deafness and vestibular disorder, DFNA9 (O

22 ome characterized by postlingual progressive sensorineural deafness as the first presenting symptom i

23 f these patients (73%) presented without the sensorineural deafness associated with Jervell and Lange

24 yndrome (JLNS) comprises profound congenital sensorineural deafness associated with syncopal episodes

25 Bilateral sensorineural deafness beginning in late childhood and e

26 before 12 months (2 before 6 months) (5/5), sensorineural deafness diagnosed soon after birth (5/5),

27 nice, and stitch, with recessively inherited sensorineural deafness due to novel mutations in the tra

28 aits of hypersensitivity to streptomycin and sensorineural deafness in a number of families from Chin

29 racterized by ovarian dysgenesis in females, sensorineural deafness in both males and females, and in

30 rative disorder characterized by progressive sensorineural deafness in combination with childhood amy

31 i, providing a molecular explanation for the sensorineural deafness in ectodermal dysplasia patients

32 nconventional myosin XVa are associated with sensorineural deafness in humans (DFNB3) and shaker (Myo

33 Sensorineural deafness in MWS, and provocation of sympto

34 s improve the diabetes, although progressive sensorineural deafness is irreversible.

35 t Cx26 and Cx30 mutations that are linked to sensorineural deafness retained ionic coupling but were

36 Autosomal recessive nonsyndromic sensorineural deafness segregating in a large consanguin

37 ous syndrome ocular albinism with late onset sensorineural deafness syndromes.

38 d fever, rashes, arthralgia, conjunctivitis, sensorineural deafness, and an intense acute-phase respo

39 syndrome characterized by neonatal diabetes, sensorineural deafness, and congenital cataracts.

40 eration, seizures, cerebellar abnormalities, sensorineural deafness, and other multisystem features.

41 deficiency - such as in hypoparathyroidism, sensorineural deafness, and renal (HDR) syndrome - by OP

42 In addition, three individuals had sensorineural deafness, and three had bronchial asthma.

43 e are tissue specific--eg, optic neuropathy, sensorineural deafness, and type 2 diabetes mellitus.

44 isability, cortical malformations, coloboma, sensorineural deafness, and typical facial features.

45 ties, severe cerebellar hypoplasia, profound sensorineural deafness, and visual impairment due to sev

46 erebellar hypoplasia, learning difficulties, sensorineural deafness, and visual impairment.

47 etabolic alkalosis associated with seizures, sensorineural deafness, ataxia, and developmental abnorm

48 cognized syndrome characterized by seizures, sensorineural deafness, ataxia, mental retardation, and

49 everal human diseases including nonsyndromic sensorineural deafness, Charcot-Marie-Tooth disease-5, a

50 hich is characterized by profound congenital sensorineural deafness, constant vestibular dysfunction

51 severe hyperinsulinism, profound congenital sensorineural deafness, enteropathy and renal tubular dy

52 utosomal recessive disorder characterized by sensorineural deafness, goiter, and impaired iodide orga

53 ed for MAF/Maf loss of function but includes sensorineural deafness, intellectual disability, seizure

54 sent in a pedigree with maternally inherited sensorineural deafness, levodopa-responsive parkinsonism

55 aracterized by CPEO, mitochondrial myopathy, sensorineural deafness, peripheral neuropathy, parkinson

56 Additional aspects of the phenotype include sensorineural deafness, reduced lifespan and decreased r

57 megaloblastic anemia, diabetes mellitus, and sensorineural deafness, responding in varying degrees to

58 ibes the association of profound, congenital sensorineural deafness, vestibular hypofunction and chil

59 Loss of Cx26 function causes nonsyndromic sensorineural deafness, without consequence in the epide

60 acid-base homeostasis, often accompanied by sensorineural deafness.

61 mutation was linked to early-onset SRNS with sensorineural deafness.

62 progressive ponto-bulbar palsy and bilateral sensorineural deafness.

63 diabetes mellitus, megaloblastic anemia, and sensorineural deafness.

64 of myosin VI causes progressive postlingual sensorineural deafness.

65 bnormalities, optic nerve colobomas and mild sensorineural deafness.

66 genital, renal, and ear anomalies, including sensorineural deafness.

67 he molecular basis of nephrotic syndrome and sensorineural deafness.

68 diabetes mellitus, megaloblastic anemia and sensorineural deafness.

69 r keratoderma associated with ichthyosis and sensorineural deafness.

70 ith autosomal recessive dRTA associated with sensorineural deafness.

71 with 35 members with the A1555G mutation and sensorineural deafness.

72 ein 1 (TBL1), whose gene is mutated in human sensorineural deafness.

73 cy-onset diabetes, congenital cataracts, and sensorineural deafness.

74 aniofrontonasal syndrome, and a nonsyndromic sensorineural deafness.

75 ve syndrome characterized by high myopia and sensorineural deafness.

76 , Abnormal genitalia, Retardation of growth, sensorineural Deafness; LS), also called Noonan syndrome

77 led Pou4f1, Pou4f2, Pou4f3, respectively) in sensorineural development and survival.

78 and -3c, which are important regulators for sensorineural development.

79 Our findings provide a link between sensorineural disease and anomalies in MT behavior and d

80 drome type IC is a rare, autosomal recessive sensorineural disorder caused by mutations in the USH1C

81 ety of biologically active agents on colonic sensorineural function in vitro has been described, the

82 tomentosa (UT) would facilitate recovery of sensorineural functions following exposure to a damaging

83 l problems in the world and can present with sensorineural healing loss.

84 showed several atypical features, including sensorineural hearing deficit, abnormal bleeding, and, m

85 improvement was defined as an improvement of sensorineural hearing from baseline, in at least one ear

86 nerally reduced or absent for listeners with sensorineural hearing impairment (HI).

87 lations) for the appropriate compensation of sensorineural hearing impairment across a range of frequ

88 nd January 2010 on screening for age-related sensorineural hearing impairment in adults aged 50 years

89 Functional simulation of sensorineural hearing impairment is an important researc

90 with a mild to severe, sloping, symmetrical, sensorineural hearing impairment were fitted with hearin

91 rates, as underlying nonsyndromic prelingual sensorineural hearing impairment.

92 , 7 with normal hearing and 7 with bilateral sensorineural hearing impairment.

93 s pigmentosa (RP) with or without congenital sensorineural hearing impairment.

94 rocessing, reduced myelination might augment sensorineural hearing impairment.

95 s (dRTA; OMIM #267300) often associated with sensorineural hearing impairment; however, mice with a k

96 articipants were 36 adults with symmetrical, sensorineural hearing loss (18 experienced hearing instr

97 fy mutations in Gipc3 underlying progressive sensorineural hearing loss (age-related hearing loss 5,

98 ressive cone-rod degeneration accompanied by sensorineural hearing loss (arCRD-SNHL).

99 Understanding of autoimmune sensorineural hearing loss (ASNHL) has been hindered by

100 Autoimmune sensorineural hearing loss (ASNHL) is characterized typi

101 Autoimmune sensorineural hearing loss (ASNHL) is the most common ca

102 d-responsive, rapidly progressive, bilateral sensorineural hearing loss (autoimmune inner ear disease

103 ocus responsible for postlingual progressive sensorineural hearing loss (designated DFNA9) that maps

104 e models for studying nonsyndromic recessive sensorineural hearing loss (DFNB7/11) in humans.

105 Non-syndromic low frequency sensorineural hearing loss (LFSNHL) affecting only 2000

106 d whole-exome sequencing in individuals with sensorineural hearing loss (SNHL) and identified pathoge

107 tacks of spontaneous vertigo associated with sensorineural hearing loss (SNHL) and tinnitus.

108 Hippel-Lindau disease and cause irreversible sensorineural hearing loss (SNHL) and vestibulopathy.

109 Dilated cardiomyopathy (DCM) and sensorineural hearing loss (SNHL) are prevalent disorder

110 Sensorineural hearing loss (SNHL) at birth was associate

111 The benefit provided to listeners with sensorineural hearing loss (SNHL) by an acoustic beamfor

112 Behavioral studies in humans suggest that sensorineural hearing loss (SNHL) decreases sensitivity

113 e to four decades, the incidence of acquired sensorineural hearing loss (SNHL) in children living in

114 We induced sensorineural hearing loss (SNHL) in developing gerbils

115 Lassa virus (LASV)-infected patients develop sensorineural hearing loss (SNHL) in the late stages of

116 Progressive bilateral sensorineural hearing loss (SNHL) is evident in approxim

117 Although sensorineural hearing loss (SNHL) is known to compromise

118 Individuals with sensorineural hearing loss (SNHL) often experience more

119 ngenital cytomegalovirus (CMV) infection and sensorineural hearing loss (SNHL) was first described al

120 In this study, sensorineural hearing loss (SNHL) was induced surgically

121 s a rare recessive disorder characterized by sensorineural hearing loss (SNHL), amelogenesis imperfec

122 terized by vascularizing keratitis, profound sensorineural hearing loss (SNHL), and progressive eryth

123 nt in young children with severe to profound sensorineural hearing loss (SNHL).

124 cardiomyopathy and heart failure preceded by sensorineural hearing loss (SNHL).

125 anial radiation therapy (RT) are at risk for sensorineural hearing loss (SNHL).

126 ficult for hearing-impaired listeners with a sensorineural hearing loss (SNHL).

127 -five percent of people with VS present with sensorineural hearing loss (SNHL); the mechanism of this

128 Sudden sensorineural hearing loss (SSNHL) is commonly encounter

129 anging from highly restricted pili torti and sensorineural hearing loss (the Bjornstad syndrome) to p

130 tic (venous thrombosis 25%, lymphedema 11%), sensorineural hearing loss 76%, miscarriage 33%, and hyp

131 Sensorineural hearing loss affects the quality of life a

132 In humans, mutations in SOX2 cause sensorineural hearing loss and a loss of function study

133 otogl with morpholinos in zebrafish leads to sensorineural hearing loss and anatomical changes in the

134 premature aging, neurological abnormalities, sensorineural hearing loss and cachectic dwarfism.

135 292 had no polyneuropathy or ataxia, and the sensorineural hearing loss and cataract were attributed

136 a good animal model to evaluate the role of sensorineural hearing loss and central inhibition in aud

137 ion in multiple tissues, suggesting that the sensorineural hearing loss and characteristic brain malf

138 ilitate early detection and intervention for sensorineural hearing loss and developmental delay, wher

139 nia, facial dysmorphology, ocular anomalies, sensorineural hearing loss and developmental delay.

140 dered in patients presenting with congenital sensorineural hearing loss and disorders of cornificatio

141 Sensorineural hearing loss and gastrointestinal disturba

142 mic deafness and characterized by congenital sensorineural hearing loss and goitre.

143 erturn a long-standing dogma in the study of sensorineural hearing loss and highlight the importance

144 ty of hearing-loss disorders, such as sudden sensorineural hearing loss and Meniere's disease that ar

145 tosomal-recessive condition characterized by sensorineural hearing loss and ovarian failure.

146 autosomal recessive disorder associated with sensorineural hearing loss and pili torti, is caused by

147 d that an absence of Np65 causes early-onset sensorineural hearing loss and prevented the normal syna

148 ant mice, absence of Np65 causes early-onset sensorineural hearing loss and prevents normal neurotran

149 disorder characterized by moderate to severe sensorineural hearing loss and progressive retinitis pig

150 disorder characterized by moderate to severe sensorineural hearing loss and progressive retinitis pig

151 racterized by progressive pontobulbar palsy, sensorineural hearing loss and respiratory insufficiency

152 der characterized by the association between sensorineural hearing loss and thyroid swelling or goitr

153 ) gene, causing the adult-onset, progressive sensorineural hearing loss and vestibular disorder at th

154 e etiologic for the late-onset, progressive, sensorineural hearing loss and vestibular dysfunction kn

155 members inherited pili torti and prelingual sensorineural hearing loss as autosomal recessive traits

156 , whereas the C57Bl/6 strain exhibits severe sensorineural hearing loss at an early age.

157 obtained from 49 participants with moderate sensorineural hearing loss before fitting and after 3 we

158 gs to more clinically relevant conditions of sensorineural hearing loss by examining the role of frac

159 that this variant may modify the severity of sensorineural hearing loss caused by a variety of factor

160 While the peripheral effects of sensorineural hearing loss certainly contribute to this

161 Both adjunctive drugs minimized or prevented sensorineural hearing loss compared with placebo.

162 oximately 20-30% of patients with congenital sensorineural hearing loss demonstrate radiographic abno

163 nalysis of dominantly inherited, progressive sensorineural hearing loss DFNA41 in a six-generation ki

164 oding connexin 26 (cx26) have been linked to sensorineural hearing loss either alone or as part of a

165 elin plasticity and how this could relate to sensorineural hearing loss following peripheral impairme

166 An increased risk of sensorineural hearing loss has been reported in such car

167 Idiopathic sudden sensorineural hearing loss has been treated with oral co

168 Studies of sensorineural hearing loss have long suggested that surv

169 either common (hearing loss) or distinctive (sensorineural hearing loss in a child), they are importa

170 t, progressive, high-frequency, nonsyndromic sensorineural hearing loss in a large, multigenerational

171 te OPG at high levels and lack of OPG causes sensorineural hearing loss in addition to the previously

172 This pathway could underlie treatable sensorineural hearing loss in DFNA34, CAPS, and possibly

173 y in lipopolysaccharide (LPS)-induced sudden sensorineural hearing loss in guinea pigs.

174 hours' duration and fluctuating, progressive sensorineural hearing loss in his left ear.

175 channel-like gene 1 (TMC1) cause progressive sensorineural hearing loss in humans and Beethoven (Tmc1

176 As EYA4 mutations cause sensorineural hearing loss in humans, we produced and ch

177 Genetic progressive sensorineural hearing loss in mice of the C57BL/6J (B6)

178 GED1 loss, and a diversity of conductive and sensorineural hearing loss in nearly half of AGS patient

179 53G > A), of NLRP3 causes autosomal-dominant sensorineural hearing loss in two unrelated families.

180 oss in which the cochleae are not damaged or sensorineural hearing loss in which both cochleae are re

181 We conclude that low-frequency sensorineural hearing loss is a characteristic feature o

182 Sensorineural hearing loss is a common and currently irr

183 Sensorineural hearing loss is a major complication for L

184 Sensorineural hearing loss is a widespread and permanent

185 e not precipitated by cold exposure and that sensorineural hearing loss is frequently also present.

186 Sensorineural hearing loss is genetically heterogeneous.

187 Progressive sensorineural hearing loss is observed in a subset of NE

188 Sudden sensorineural hearing loss is usually unilateral and can

189 sly unknown autosomal-recessive nonsyndromic sensorineural hearing loss locus (DFNB91) to chromosome

190 Isolated sensorineural hearing loss occurred in 3%.

191 SSNHL is most commonly defined as sensorineural hearing loss of 30 dB or greater over at l

192 more likely than controls to have bilateral sensorineural hearing loss of 40 dB or more (unmatched 1

193 s a higher risk of adverse neonatal outcome (sensorineural hearing loss or neurological deficits).

194 otitis media (OM), including high-frequency sensorineural hearing loss or vertigo, is not uncommon.

195 regating an autosomal dominant, progressive, sensorineural hearing loss phenotype that has been linke

196 man with a history of progressive bilateral sensorineural hearing loss presented to a neuro-ophthalm

197 trial involving 250 patients with unilateral sensorineural hearing loss presenting within 14 days of

198 mbrane abnormalities may be one aetiology of sensorineural hearing loss primarily affecting the mid-f

199 year-old female has intellectual disability, sensorineural hearing loss requiring bilateral cochlear

200 Sensorineural hearing loss results from damage to the ha

201 transcriptional co-activator EYA4 gene cause sensorineural hearing loss that can occur in association

202 describe 2 unrelated pedigrees with MTP and sensorineural hearing loss that segregate with a DIAPH1

203 Sensorineural hearing loss was present in some, and deve

204 l prednisone for primary treatment of sudden sensorineural hearing loss was rejected.

205 The clinical association of sensorineural hearing loss with pili torti (broken, twis

206 to DFNA9, a nonsyndromic autosomal dominant sensorineural hearing loss with vestibular defects.

207 utosomal dominant, nonsyndromic, progressive sensorineural hearing loss with vestibular pathology.

208 sease erythrokeratoderma variabilis (EKV) or sensorineural hearing loss with/without peripheral neuro

209 She had also had mild sensorineural hearing loss within the previous 2 weeks.

210 However, whether sensorineural hearing loss would affect central auditory

211 sequential probands referred for congenital sensorineural hearing loss, 22 (42%) were found to have

212 who presented with osteoporosis, cataracts, sensorineural hearing loss, and mild learning defects.

213 s much to learn about pathogenesis of sudden sensorineural hearing loss, and more clinical trials are

214 wo thirds of respondents were male, most had sensorineural hearing loss, and most were older than 50;

215 al-recessive inheritance, severe to profound sensorineural hearing loss, and partial agenesis of the

216 nction, cachetic dwarfism, photosensitivity, sensorineural hearing loss, and retinal degradation.

217 llar ataxia, early-onset cerebellar atrophy, sensorineural hearing loss, and the distinctive associat

218 etely penetrant, predominantly low-frequency sensorineural hearing loss, and the Fgfr3(P244R) mice sh

219 spontaneous attacks of vertigo, fluctuating sensorineural hearing loss, aural fullness, and tinnitus

220 cause of neurological problems, particularly sensorineural hearing loss, but data on long-term sequel

221 vide significant benefit for a wide range of sensorineural hearing loss, but no carefully controlled,

222 cterized by pigmentary retinal degeneration, sensorineural hearing loss, childhood obesity, non-insul

223 disability, hypotonia, spasticity, seizures, sensorineural hearing loss, cortical visual impairment,

224 plantation, the current therapy for profound sensorineural hearing loss, depends on a functional nerv

225 rophy, neuropathy, myopathy, cardiomyopathy, sensorineural hearing loss, diabetes mellitus, and other

226 results in vertebral compression fractures, sensorineural hearing loss, eye defects, and heart defec

227 bers show a bilateral, sloping, progressive, sensorineural hearing loss, first evident at 6000 and 80

228 Among patients with idiopathic sudden sensorineural hearing loss, hearing level 2 months after

229 cted in two unrelated persons with increased sensorineural hearing loss, in the other caused by a mut

230 coustic trauma, one of the leading causes of sensorineural hearing loss, induces sensory hair cell da

231 sible causes of hearing loss, such as sudden sensorineural hearing loss, is important to maximize the

232 syndrome that includes the subacute onset of sensorineural hearing loss, often accompanied by vertigo

233 verlapping clinical features, manifesting as sensorineural hearing loss, often associated with vertig

234 racterized by mental retardation, hypotonia, sensorineural hearing loss, optic atrophy, and other fea

235 autosomal dominant disorder characterized by sensorineural hearing loss, palmoplantar keratoderma, kn

236 iginally identified in Persian families with sensorineural hearing loss, regulates peroxisomal dynami

237 ic TBS patients by displaying high-frequency sensorineural hearing loss, renal cystic hypoplasia and

238 cochlea, caused by macular degeneration and sensorineural hearing loss, respectively, affect a growi

239 In acquired sensorineural hearing loss, such as that produced by noi

240 of hair cells or auditory neurons results in sensorineural hearing loss, the consequence of supportin

241 chronic disorder of the inner ear defined by sensorineural hearing loss, tinnitus and episodic vertig

242 ting from minutes to hours, with fluctuating sensorineural hearing loss, tinnitus, and aural pressure

243 rized by fever, chronic meningitis, uveitis, sensorineural hearing loss, urticarial skin rash, and a

244 essive disorder characterized by progressive sensorineural hearing loss, vestibular dysfunction, and

245 Sensorineural hearing loss, which stems primarily from t

246 anguineous family with moderate nonsyndromic sensorineural hearing loss.

247 ory-filter characteristics of listeners with sensorineural hearing loss.

248 ogenitors and mutations in these genes cause sensorineural hearing loss.

249 of the inner ear, which ultimately leads to sensorineural hearing loss.

250 recurring episodes of sudden or progressive sensorineural hearing loss.

251 lit-foot type 1 malformation associated with sensorineural hearing loss.

252 rder characterized by ovarian dysgenesis and sensorineural hearing loss.

253 ardiomyopathy, kidney and liver disease, and sensorineural hearing loss.

254 of this protection results in cell death and sensorineural hearing loss.

255 Hair cell loss is a major cause of sensorineural hearing loss.

256 ng GJB2 gene lead to many skin disorders and sensorineural hearing loss.

257 obodontia) segregating with a high-frequency sensorineural hearing loss.

258 own as a major target antigen for autoimmune sensorineural hearing loss.

259 lar disease associated with a high-frequency sensorineural hearing loss.

260 auses is irreversible and leads to permanent sensorineural hearing loss.

261 ice hear well initially but show progressive sensorineural hearing loss.

262 ent and prognosis for patients with profound sensorineural hearing loss.

263 trated to improve outcomes for patients with sensorineural hearing loss.

264 l dominant form of progressive non-syndromic sensorineural hearing loss.

265 mice had a hyperactive circling behavior and sensorineural hearing loss.

266 pigmentary retinopathy and/or cataracts, and sensorineural hearing loss.

267 mentary retinopathy, cataracts, or both; and sensorineural hearing loss.

268 e witnessed a revolution in the treatment of sensorineural hearing loss.

269 ous parents and had an early onset bilateral sensorineural hearing loss.

270 g mental retardation, vision impairment, and sensorineural hearing loss.

271 significant cause of morbidity, particularly sensorineural hearing loss.

272 mited due to serious side effects, including sensorineural hearing loss.

273 DFNBL, for autosomal recessive non-syndromic sensorineural hearing loss.

274 ed by progressive pigmentary retinopathy and sensorineural hearing loss.

275 (p.Trp24*), which is an established cause of sensorineural hearing loss.

276 circuits, and its mutation may contribute to sensorineural hearing loss.

277 siblings had poor balance and 1 sibling had sensorineural hearing loss.

278 ontine angle, and it typically presents with sensorineural hearing loss.

279 with a broad clinical spectrum that includes sensorineural hearing loss.

280 ble in the adult mammalian ear, resulting in sensorineural hearing loss.

281 s a rare disease that results in progressive sensorineural hearing loss.

282 ipheral facial paralysis and 2 patients with sensorineural hearing loss.

283 siblings presented with autosomal recessive sensorineural hearing loss: two had high-frequency loss,

284 Patients with ATP6B1 mutations also have sensorineural hearing loss; consistent with this finding

285 ven adults (50-76 years) with mild to severe sensorineural hearing participated in the study.

286 nsity and increases in skeletal rigidity and sensorineural hearing within patient subgroups.

287 Noise exposure produced significant sensorineural impairments.

288 ng loss in older adults, is a multifactorial sensorineural loss that frequently includes a component

289 518Dfs*2) in an Italian pedigree affected by sensorineural mild-to-moderate HHL but also showing a va

290 ast, children with SLI showed no evidence of sensorineural modulation with attention, despite behavio

291 ns of mice have different predispositions to sensorineural pathway activation, we quantified expressi

292 These findings expand our understanding of sensorineural plasticity in adult vestibular organs and

293 ta3 is expressed in a distinct population of sensorineural precursor cells within the otic epithelium

294 the effects of selective attention on early sensorineural processing may give rise to the diverse se

295 omal dominant, fully penetrant, nonsyndromic sensorineural progressive hearing loss in a large Costa

296 DFNB3, a locus for nonsyndromic sensorineural recessive deafness, maps to a 3-centimorga

297 ping children showed an amplification of the sensorineural response to attended as compared to unatte

298 of infected fetuses will have neurologic or sensorineural sequelae at birth or later in life.

299 enerated to investigate the role of NaBC1 in sensorineural systems.

300 ial candidate gene in patients with isolated sensorineural vestibular hearing abnormalities.